Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 8, 2015

Primary Completion Date

April 1, 2016

Study Completion Date

April 30, 2023

Conditions

Dystrophic Epidermolysis Bullosa

Interventions

OTHER

Allogeneic mesenchymal stem cells

Dressing for Dystrophic Epidermolysis Bullosa wound.

DEVICE

Polyurethene Film

Dressing for Dystrophic Epidermolysis Bullosa wound.

Trial Locations (1)

Gangnam Severence Hospital, Seoul

All Listed Sponsors

lead

Anterogen Co., Ltd.

INDUSTRY

NCT02579369 - Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa | Biotech Hunter | Biotech Hunter